Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
- PMID: 12816821
- PMCID: PMC162124
- DOI: 10.1136/bmj.326.7403.1358
Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
Abstract
Objectives: To evaluate the haematological findings of patients with severe acute respiratory syndrome (SARS).
Design: Analysis of the demographic, clinical, and laboratory characteristics of patients with SARS.
Setting: Prince of Wales Hospital, Hong Kong. Subjects All patients with a diagnosis of SARS between 11 March and 29 March 2003 who had no pre-existing haematological disorders.
Main outcome measures: Clinical end points included the need for intensive care and death. Univariate and multivariate analyses were performed to examine factors associated with adverse outcome.
Results: 64 male and 93 female patients were included in this study. The most common findings included lymphopenia in 153 (98%) of the 157 patients, neutrophilia in 129 (82%), thrombocytopenia in 87 patients (55%), followed by thrombocytosis in 77 (49%), and isolated prolonged activated partial thromboplastin time in 96 patients (63%). The haemoglobin count dropped by more than 20 g/l from baseline in 95 (61%) patients. Four patients (2.5%) developed disseminated intravascular coagulation. Lymphopenia was shown in haemato-lymphoid organs at postmortem examination. Multivariate analysis showed that advanced age and a high concentration of lactate dehydrogenase at presentation were independent predictors of an adverse outcome. Subsets of peripheral blood lymphocytes were analysed in 31 patients. The counts of CD4 positive and CD8 positive T cells fell early in the course of illness. Low counts of CD4 and CD8 cells at presentation were associated with adverse outcomes.
Conclusions: Abnormal haematological variables were common among patients with SARS. Lymphopenia and the depletion of T lymphocyte subsets may be associated with disease activity.
Figures
Comment in
-
SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS.BMJ. 2003 Sep 13;327(7415):620. doi: 10.1136/bmj.327.7415.620-b. BMJ. 2003. PMID: 12969939 Free PMC article. No abstract available.
-
Real time assay of Aspergillus should be used in SARS patients receiving corticosteroids.BMJ. 2003 Dec 13;327(7428):1405. doi: 10.1136/bmj.327.7428.1405. BMJ. 2003. PMID: 14670903 Free PMC article. No abstract available.
Similar articles
-
[Difference and significance of T-lymphocyte subsets in differential diagnosis between severe acute respiratory syndrome and common atypical pneumonia].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Jun;18(2):137-41. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004. PMID: 15340501 Chinese.
-
[Changes of blood cells in patients with severe acute respiratory syndrome].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003 Dec;17(4):344-5. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003. PMID: 15340548 Chinese.
-
Rapid loss of both CD4+ and CD8+ T lymphocyte subsets during the acute phase of severe acute respiratory syndrome.Chin Med J (Engl). 2003 Jul;116(7):985-7. Chin Med J (Engl). 2003. PMID: 12890367
-
Severe acute respiratory distress syndrome (SARS): a critical care perspective.Crit Care Med. 2003 Nov;31(11):2684-92. doi: 10.1097/01.CCM.0000091929.51288.5F. Crit Care Med. 2003. PMID: 14605542 Review.
-
Coronavirus Disease 2019 (COVID-19): A Haematologist's Perspective.Acta Haematol. 2021;144(1):10-23. doi: 10.1159/000510178. Epub 2020 Jul 28. Acta Haematol. 2021. PMID: 32721958 Free PMC article. Review.
Cited by
-
Naturally activated adaptive immunity in COVID-19 patients.J Cell Mol Med. 2020 Nov;24(21):12457-12463. doi: 10.1111/jcmm.15771. Epub 2020 Sep 25. J Cell Mol Med. 2020. PMID: 32975374 Free PMC article.
-
Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?Pathogens. 2021 Apr 14;10(4):476. doi: 10.3390/pathogens10040476. Pathogens. 2021. PMID: 33920011 Free PMC article. Review.
-
Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.J Virol. 2015 Apr;89(7):3870-87. doi: 10.1128/JVI.03566-14. Epub 2015 Jan 21. J Virol. 2015. PMID: 25609816 Free PMC article.
-
Abnormal immunity of non-survivors with COVID-19: predictors for mortality.Infect Dis Poverty. 2020 Aug 3;9(1):108. doi: 10.1186/s40249-020-00723-1. Infect Dis Poverty. 2020. PMID: 32746940 Free PMC article.
-
Short-term outcome of critically ill patients with severe acute respiratory syndrome.Intensive Care Med. 2004 Mar;30(3):381-7. doi: 10.1007/s00134-003-2143-y. Epub 2004 Jan 23. Intensive Care Med. 2004. PMID: 14740156 Free PMC article.
References
-
- Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348: 1986-94. - PubMed
-
- Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348: 1953-66. - PubMed
-
- Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348: 1995-2005. - PubMed
-
- Outbreak of severe acute respiratory syndrome--worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003;52: 226-8. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous